Skip to main content

Table 2 A subgroup analysis of the prevalence of depressive symptoms among HIV AIDS patients in Ethiopia with its 95% confidence interval

From: Depressive symptoms and their determinants in patients who are on antiretroviral therapy in the case of a low-income country, Ethiopia: a systematic review and meta-analysis

Subgroup

Number of studies

Estimates

Heterogeneity

Prevalence (%)

95% CI

I2

Q(DF)

P-value

Study setting

 North western Ethiopia (Amhara region)

5

31.16

17.43, 44.89

96.2%

185.27 (4)

P < 0.001

 South western Ethiopia(Oromia region)

3

59.43

42.44, 76.42

99.5%

403.2 (2)

P < 0.001

 Tigray region

3

38.8

14.66, 62.94

94.8%

212 (2)

P < 0.001

 Central Ethiopia(Addis Ababa)

6

30.61

18.82, 42.41

92. 2%

95.43 (5)

P < 0.001

 Southern Ethiopia

4

29.25

11.45, 47.05

96%

164.20 (3)

P < 0.001

Assessment tool used

 PHQ-9

12

37.62

30.05, 45.17

98.8%

521.45 (11)

P < 0.001

 HADS

2

26.2

3.20, 55.60

94.6%

453.21 (1)

P < 0.001

 CES-D

3

32.37

− 14.05, 78.79

96.4%

496.32 (2)

P < 0.001

 BDI

2

45.6

25.76, 66.54

92.6%

243.40 (1)

P < 0.001

 Others*

2

29.4

1.13, 55.77

98.6%

502.65 (1)

P < 0.001

Sample size studied

 ≤ 400

8

47.7

36.73, 58.57

99%

232.21 (7)

P < 0.001

 > 400 

13

28.5

20.21, 36.72

96.8%

136.35 (12)

P < 0.001

Year of publication

 After 2015

11

40

31.17, 48.89

96.6%

221.22 (10)

P < 0.001

  2015 and before

10

31.1

19.62, 42.56

98%

311.37 (9)

P < 0.001

  1. Others* Includes HAM-D & Kessler-6, DF Degree of Freedom, CI confidence interval